Sanner Introduces AdPack Desiccant Pillow Pack Family
Sanner GmbH, a manufacturer of high-quality plastic packaging for pharmaceutical, medical and healthcare products, is expanding its portfolio with the new AdPack desiccant pillow packs — an efficient, economical and safe solution for the protection of moisture-sensitive pharmaceuticals such as tablets and capsules inside the packaging.
2014 is the year of product innovations at Sanner. Following the market launch of the Brilliance Tubes for decorated packaging, the company introduces another new product at CPHI Worldwide. “With the AdPack desiccant pillow packs, we have developed a new drop-in solution for moisture protection inside the packaging,” explains Sanner CEO Holger Frank. “This offers our customers a cost-efficient solution that unites all the advantages of GMP-compliant production, professional risk management, 100% traceability and outstanding Sanner quality.”
The AdPack product family consists of desiccant pillow packs that are filled into the packaging along with the drugs, thus protecting them against moisture. Designed for pharma applications worldwide, AdPack complies with all relevant European and FDA regulations for contact with food and drugs. The products are also listed in a Type III Drug Master File (DMF).
Suitable for Pharmaceutical Applications
The pillow packs are available as single strips or on reel, and are made of industry-leading, extremely durable, and tear-resistant Tyvek material. AdPack is highly permeable and ensures long-term adsorption of moisture and odors. Due to the flexible non-dusting, lint-free Tyvek material, the packaged pharmaceuticals remain intact at all times. The low-profile AdPack desiccant pillow packs take up little space within a package. Their distinct shape eliminates potential confusion with capsules or tablets, and prevents accidental ingestion.
To maximise flexibility for customers, AdPack is compatible with standard semi- and fully-automated dispensing equipment and filling lines. Depending on the type of machine, AdPack is available as single pillow packs or as strips on reel. Thanks to a punch hole in the sealing seam, AdPack on reel ensures a clean pack separation during the dispensing process.
Complete Pharma Desiccant Packaging Portfolio
At CPHI Worldwide in Paris from 7 to 9 October 2014 (booth 2K61), Sanner will present the new AdPack desiccant pillow packs to industry professionals for the first time. “CPHI Worldwide is an ideal platform for the AdPack market launch. Moreover, our visitors will receive an overview of the different solutions from our product category pharma desiccant packaging,” says Holger Frank.
In addition to integrated desiccant solutions, Sanner will also showcase another drop-in solution — the AdCap desiccant capsules. They adsorb moisture through a cardboard disc on the top, as well as through a unique grid structure on the side of the capsule. This ensures moisture adsorption after filling, even when the capsule is lying on the cardboard side.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.